AKTX Stock Analysis: Buy, Sell, or Hold?
AKTX - Akari Therapeutics plc ADR (0.01 USD)
$7.44
-0.29 (-3.75%)
▼
5d:
-0.8%
30d:
-44.56%
90d:
+143.14%
HOLD
LOW Confidence
Analysis Updated: Aug 11, 2026 12:00 AM ET
Earnings: Aug 12, 2026
0d
Get Alerted When AKTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AKTX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AKTX is currently trading at $7.44, which is considered oversold relative to its 30-day fair value range of $7.45 to $12.42.
Technical Outlook: Technically, AKTX is in a uptrend. Immediate support is located at $7.00, while resistance sits at $8.63. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: AKTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.39 (+267.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AKTX is in a uptrend. Immediate support is located at $7.00, while resistance sits at $8.63. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: AKTX scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $28.39 (+267.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.45 -
$12.42
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 267.3% below Wall St target ($28.39)
- CAUTION: Bottoming setup, but lagging the sector by 38% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$7.45 -
$12.42
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$7.00
Resistance Level
$8.63
Current Trend
Uptrend
Technical data as of
Aug 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.04
Wall Street Target
$28.39
(+267.3%)
Share & Embed Analysis
Last updated: August 12, 2026 12:55 PM ET
Data refreshes hourly during market hours. Next update: 1:55 PM
Data refreshes hourly during market hours. Next update: 1:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AKTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 53 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 58 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 35 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$281 | 52 HOLD |
|
TNYA
Tenaya Therapeutics Inc |
STRONG BUY
9 analysts |
$3 | 72 BUY |
